サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1301122

徐放性賦形剤の市場規模、シェア、動向分析レポート：投与経路別、技術別、製品別、地域別、セグメント予測、2023年～2030年

Sustained Release Excipients Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Transdermal), By Technology (Transdermal, Implants), By Product (Gelatin, Sugars), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
徐放性賦形剤の市場規模、シェア、動向分析レポート：投与経路別、技術別、製品別、地域別、セグメント予測、2023年～2030年
出版日: 2023年06月22日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

徐放性賦形剤市場の成長と動向

GrandView Research, Inc.の最新レポートによると、世界の徐放性賦形剤市場規模は2023年から2030年にかけてCAGR 8.4%で拡大し、2030年には23億6,000万米ドルに達する見込みです。

徐放性賦形剤市場の成長は、徐放性医薬品に対する需要の増加、患者のコンプライアンス率の向上、従来の方法と比較したこのドラッグデリバリー方法の複数の利点に起因しています。これらの賦形剤は通常、カプセルや錠剤として使用され、薬剤をゆっくりと放出させる。そのため、薬剤を服用する間隔が短くなり、即時放出型製剤よりも有利になります。賦形剤の崩壊、溶解、分解による徐放化は、薬物の徐放化につながります。

投与回数の減少、患者のコンプライアンスの改善、血漿中の薬物濃度の一定維持、過剰投与による毒性の発生率の低下、長期的な費用対効果の向上などは、徐放性ドラッグデリバリーシステムを使用する主な利点の一部です。従来の経口薬を常用すると、一般に胃腸の不調、痙攣、吐き気、下痢などの望ましくない症状が生じる。徐放性薬物製剤の使用により、患者はこれらの症状から解放され、体内で望ましい治療薬物レベルを維持することができます。さらに、これらは徐放性製剤の採用を増加させており、患者のコンプライアンス向上と治療効果の改善を可能にしています。

ここ数年、抗生物質耐性が世界的に増加しています。抗生物質耐性の主な原因として、従来の製剤の乱用や誤用が指摘されています。場合によっては、患者は薬剤投与後数日で回復し、推奨された用量の薬剤を中止します。このような耐性は、医療費の増加、入院期間の長期化、死亡率の上昇につながります。感染症や慢性疾患の増加も抗生物質耐性をもたらし、従来の剤形市場に悪影響を及ぼしています。そのため、これらの疾患を治療・管理するための代替手段が導入されつつあります。

放出制御製剤は、抗生物質耐性を防ぐために医師の間で広く受け入れられています。これらの製剤は血漿中に好ましい治療薬レベルを生成し、投与頻度を減少させるため、医師の間で理想的な選択肢となっており、業界での需要が増加しています。COVID-19パンデミックによる数カ国の封鎖や輸送・渡航禁止によって影響を受ける医薬品生産への混乱、ひいては賦形剤需要への影響は、比較的短期的なものであろう。しかし、各国における長期の封鎖による供給の混乱は、経口固形製剤の医薬品製造に大きな影響を与える可能性があります。

これはひいては、賦形剤の需要成長に世界的に大きな影響を与えると思われます。フランス、スペイン、イタリアを含む欧州では、業界の成長余地が大きいです。これは、これらの国々で先端医薬品の採用が増加しているためです。さらに、欧州医薬品庁（EMA）や医薬品・ヘルスケア製品規制庁（MHRA）などの規制当局は、この地域で高い安全基準を確保し、低コストの医薬品を容易に入手できるようにするために絶えず取り組んでいます。可処分所得の高さ、洗練されたヘルスケアインフラ、製品認可の増加は、欧州における成長機会を生み出すと期待されています。

同市場の主要企業は、医薬品業界における消費者の要求の変化に継続的に対応するため、新製品を投入しています。例えば、2022年11月、Roquette Freres社は、圧縮製剤における原薬の徐放性を高めるPearlitol CR-Hの発売を発表しました。この製品は、打錠工程をさらに強化し、競争力を高める。

徐放性賦形剤市場レポートハイライト

  • ポリマー製品セグメントが2022年に最大シェアを占める徐放性製剤におけるポリマーの多様な用途が業界の成長を促進すると予想される
  • 従来の経口投与ルートがこのセグメントの急成長に貢献保管、投与量の事前測定、携帯性、非侵襲性などの利便性が、経皮投与経路の採用を加速している主な要因です。
  • 経皮パッチの採用が増加していることが、このセグメントの急成長に寄与しています。
  • 多くの業界プレーヤーが強力な製品ポートフォリオを有しているため、2022年には標的ドラッグデリバリーが最大の売上シェアを占める。移植可能な徐放性ドラッグデリバリーシステムは、効率性、副作用の低減、利便性の向上を実現しており、これが同分野の成長を後押ししています。
  • 北米は研究開発への投資が高く、高度な技術が利用可能であるため、2022年の世界産業は北米が優位を占める
  • アジア太平洋地域は、インドや中国などの新興国で医薬品産業が成長しているため、予測期間中に最も速いCAGRを記録すると予測されています。
  • 主要市場プレイヤーの一例としては、Roquette Freres、BASF、International Flavors &Fragrances, Inc.、Ashland、Evonik Industries AG、Croda International Plc、Gattefosseなどが挙げられます。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • セグメントの定義
  • 地域の範囲
  • 推定・予測のタイムライン
  • 目的
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の形成と検証
  • モデル詳細
    • 商品フロー分析
  • 二次情報のリスト
  • 略語のリスト

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/アンシラリー市場見通し
  • 市場動向と展望
  • 市場力学
    • 従来の剤形に比べてメリットが増加
    • 小児および高齢者向けの徐放性剤形の必要性
    • 抗生物質耐性
  • 市場抑制要因分析
    • 用量ダンピングによる薬物毒性
    • 高用量のAPIが必要
  • 事業環境分析
    • SWOT分析;要因別（政治・法律、経済・技術）
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析
  • 市場機会と課題の分析

第4章 製品ビジネス分析

  • 徐放性賦形剤市場：製品変動分析
  • ゼラチン
  • ポリマー
  • ミネラル
  • 砂糖
  • アルコール
  • キトサン

第5章 技術ビジネス分析

  • 徐放性賦形剤市場：技術変動分析
  • 標的デリバリー
  • マイクロカプセル化
  • Wurster法
  • 経皮
  • インプラント
  • コアセルベーション
  • その他

第6章 投与経路ビジネス分析

  • 徐放性賦形剤市場：投与経路変動分析
  • 経口
  • 筋肉内
  • 皮下
  • 経皮
  • 膣
  • 眼科
  • 静脈内
  • その他

第7章 地域ビジネス分析

  • 地域別徐放性賦形剤市場シェア、2022年および2030年
  • 北米
    • SWOT分析
    • 北米徐放性賦形剤市場、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • SWOT分析
    • 欧州の徐放性賦形剤市場、2018～2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • SWOT分析
    • アジア太平洋地域の徐放性賦形剤市場、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • SWOT分析
    • ラテンアメリカの徐放性賦形剤市場、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • SWOT分析
    • MEA徐放性賦形剤市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 会社の分類
  • 戦略マッピング
    • 新製品の発売
    • パートナーシップ
    • 取得
    • コラボレーション
    • 資金調達
  • 主要企業の市場シェア分析、2022年
  • 企業プロファイル
    • BASF SE
    • International Flavors &Fragrances, Inc.
    • Ashland Global
    • Evonik Industries Inc
    • Croda International Plc
    • Gattefosse
    • Merck KGaA
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7 Global Sustained Release Excipients Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 North America Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 Canada Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Europe Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Europe Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Europe Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 22 Germany Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Germany Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Germany Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 UK Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 UK Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 UK Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 France Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 France Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 France Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 Italy Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Italy Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Italy Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 34 Spain Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Spain Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Spain Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Denmark Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Denmark Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 Sweden Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Sweden Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Sweden Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Norway Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Norway Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Norway Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 50 China Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 China Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 China Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 Japan Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 India Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 India Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 India Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 59 South Korea Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 South Korea Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Australia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Australia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Australia Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Thailand Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 66 Thailand Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 Thailand Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 68 Latin America Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 70 Latin America Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 Latin America Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 72 Brazil Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Brazil Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Brazil Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 75 Mexico Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 Mexico Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 77 Mexico Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 79 Argentina Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 Argentina Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Sustained Release Excipients Market, by Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 South Africa Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 South Africa Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 UAE Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 UAE Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 93 UAE Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Sustained Release Excipients Market, by Product, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Sustained Release Excipients Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Sustained Release Excipients Market, by Technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Sustained Release Excipients Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Sustained Release Excipients Market: by Product Movement Analysis
  • Fig. 16 Global Sustained Release Excipients Market, for Gelatin, 2018 - 2030 (USD Million)
  • Fig. 17 Global Sustained Release Excipients Market, for Polymers, 2018 - 2030 (USD Million)
  • Fig. 18 Global Sustained Release Excipients Market, for Minerals, 2018 - 2030 (USD Million)
  • Fig. 19 Global Sustained Release Excipients Market, for Sugars, 2018 - 2030 (USD Million)
  • Fig. 20 Global Sustained Release Excipients Market, for Alcohol, 2018 - 2030 (USD Million)
  • Fig. 21 Global Sustained Release Excipients Market, for Chitosan, 2018 - 2030 (USD Million)
  • Fig. 22 Global Sustained Release Excipients Market: Technology Movement Analysis
  • Fig. 23 Global Sustained Release Excipients Market, for Targeted Delivery, 2018 - 2030 (USD Million)
  • Fig. 24 Global Sustained Release Excipients Market, for Micro Encapsulation, 2018 - 2030 (USD Million)
  • Fig. 25 Global Sustained Release Excipients Market, for Wurster Technique, 2018 - 2030 (USD Million)
  • Fig. 26 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
  • Fig. 27 Global Sustained Release Excipients Market, for Implants, 2018 - 2030 (USD Million)
  • Fig. 28 Global Sustained Release Excipients Market, for Coacervation, 2018 - 2030 (USD Million)
  • Fig. 29 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global Sustained Release Excipients Market: Route of Administration Movement Analysis
  • Fig. 31 Global Sustained Release Excipients Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 32 Global Sustained Release Excipients Market, for Intramuscular, 2018 - 2030 (USD Million)
  • Fig. 33 Global Sustained Release Excipients Market, for Subcutaneous, 2018 - 2030 (USD Million)
  • Fig. 34 Global Sustained Release Excipients Market, for Transdermal, 2018 - 2030 (USD Million)
  • Fig. 35 Global Sustained Release Excipients Market, for Vaginal, 2018 - 2030 (USD Million)
  • Fig. 36 Global Sustained Release Excipients Market, for Ophthalmic, 2018 - 2030 (USD Million)
  • Fig. 37 Global Sustained Release Excipients Market, for Intravenous, 2018 - 2030 (USD Million)
  • Fig. 38 Global Sustained Release Excipients Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 39 Sustained Release Excipients Market :Regional Outlook, 2022 & 2030, 2018 - 2030 (USD Million)
  • Fig. 40 North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait Sustained Release Excipients Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-575-5

Sustained Release Excipients Market Growth & Trends

The global sustained release excipients market size is expected to reach USD 2.36 billion by 2030, expanding at a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the sustained-release excipients market is attributable to the growing demand for sustained-release drugs, the improvement in patient compliance rate, and the multiple advantages of this drug-delivery method over conventional methods. These excipients are usually used as capsules and tablet formulations to release the drug slower; thereby, the drug has to be taken at less frequent intervals making it advantageous over immediate-release formulations. The sustained release of excipients' disintegration, dissolution, or degradation leads to the modified slower drug release.

Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using sustained release drug delivery systems. Regular consumption of oral conventional drugs generally results in undesired symptoms, such as gastrointestinal upset, cramps, nausea, and diarrhea. The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. Moreover, these have been increasing the adoption of sustained-release formulations, enabling higher patient compliance and improved therapeutic effect.

Over the past few years, there has been a global rise in antibiotic resistance. Overuse and misuse of conventional drug formulations have been identified as the major cause of antibiotic resistance. In some instances, patients recover within a few days of drug administration and discontinue the recommended dose of drugs, culminating in resistance. Such resistance leads to higher medical costs, longer hospital stays, and a rise in mortality rate. The rise in the incidence of infectious and chronic diseases has also resulted in antibiotic resistance, which has negatively impacted the conventional dosage forms market. Thus, alternative procedures to treat and manage these diseases are being implemented.

Controlled release formulations have been extensively accepted among physicians to prevent antibiotic resistance. Since these formulations generate preferred therapeutic drug levels in blood plasma and decrease the dosage frequency, they are an ideal choice among physicians, increasing their demand in the industry. The impact of disruptions on pharmaceutical production and subsequently on excipient demand affected by lockdowns and transport and travel bans across several countries due to the COVID-19 pandemic will be comparatively short-term. However, the supply disruptions due to extended lockdowns in different countries may substantially impact the oral solid dosage form drug manufacturing.

This, in turn, will significantly impact the excipients' demand growth globally. There is a wide scope for industry growth in Europe, including France, Spain, and Italy. This is due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines & Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs in this region. High disposable income, sophisticated healthcare infrastructure, and a rise in product approvals are expected to create growth opportunities in Europe.

Key players in the market are introducing new products to continuously meet the changing requirements of consumers in the pharmaceutical industry. For instance, in November 2022, Roquette Freres announced the launch of Pearlitol CR-H, enhancing API's sustained release in compression formulations. It further enhances the tableting process giving it a competitive edge.

Sustained Release Excipients Market Report Highlights

  • Polymers product segment accounted for the largest share in 2022. Varied usage of polymers in sustained-release formulations is anticipated to fuel industry growth
  • Conventional use of the oral delivery route has contributed to the fastest growth of the segment. Convenience, in terms of storage, premeasured doses, portability, and the noninvasive nature of this route are some of the major factors accelerating its adoption
  • The rising adoption of transdermal patches has contributed to the fastest growth of the segment
  • Targeted drug delivery constituted the largest revenue share in 2022, as a large number of industry players have strong product portfolios. Implantable sustained-release drug delivery systems have improved efficiency, lower adverse effects, and higher convenience, which impels segment growth
  • North America dominated the global industry in 2022 owing to the high investments in R&D and the availability of highly sophisticated technologies in the region
  • Asia Pacific is projected to register the fastest CAGR during the forecast period due to the growing pharmaceutical industry in emerging countries, such as India and China
  • A few of the key market players include Roquette Freres, BASF, International Flavors & Fragrances, Inc., Ashland, Evonik Industries AG, Croda International Plc, and Gattefosse

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Segment
      • 1.1.1.2 Technology Segment
      • 1.1.1.3 Route Of Administration Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increased benefits over conventional dosage forms
    • 3.4.2. Necessity of pediatric and geriatric sustained release dosage forms
    • 3.4.3. Antibiotic resistance
  • 3.5. Market Restraint Analysis
    • 3.5.1. Drug toxicity due to dose dumping
    • 3.5.2. Need for high dose of API
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis
  • 3.8. Market Opportubnity and Challenge Analysis

Chapter 4. Product Business Analysis

  • 4.1. Sustained Release Excipients Market: Product Movement Analysis
  • 4.2. Gelatin
    • 4.2.1. Gelatin Market, 2018 - 2030 (USD Million)
  • 4.3. Polymers
    • 4.3.1. Polymers Market, 2018 - 2030 (USD Million)
  • 4.4. Minerals
    • 4.4.1. Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Sugars
    • 4.5.1. Sugars Market, 2018 - 2030 (USD Million)
  • 4.6. Alcohols
    • 4.6.1. Alcohols Market, 2018 - 2030 (USD Million)
  • 4.7. Chitosan
    • 4.7.1. Chitosan Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Sustained Release Excipients Market: Technology Movement Analysis
    • 5.1.1. Targeted Delivery
  • 5.2. Targeted Delivery Market, 2018 - 2030 (USD Million)
    • 5.2.1. Micro Encapsulation
  • 5.3. Micro Encapsulation Market, 2018 - 2030 (USD Million)
    • 5.3.1. Wurster Technique
  • 5.4. Wurster Technique Market, 2018 - 2030 (USD Million)
    • 5.4.1. Transdermal
  • 5.5. Transdermal Market, 2018 - 2030 (USD Million)
    • 5.5.1. Implants
  • 5.6. Implants Market, 2018 - 2030 (USD Million)
    • 5.6.1. Coacervation
  • 5.7. Coacervation Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Sustained Release Excipients Market: Route of Administration Movement Analysis
  • 6.2. Oral
    • 6.2.1. Oral Market, 2018 - 2030 (USD Million)
  • 6.3. Intramuscular
    • 6.3.1. Intramuscular Market, 2018 - 2030 (USD Million)
  • 6.4. Subcutaneous
    • 6.4.1. Subcutaneous Market, 2018 - 2030 (USD Million)
  • 6.5. Transdermal
    • 6.5.1. Transdermal Market, 2018 - 2030 (USD Million)
  • 6.6. Vaginal
    • 6.6.1. Vaginal Market, 2018 - 2030 (USD Million)
  • 6.7. Ophthalmic
    • 6.7.1. Ophthalmic Market, 2018 - 2030 (USD Million)
  • 6.8. Intravenous
    • 6.8.1. Intravenous Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Sustained Release Excipients Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. Germany Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. UK Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. South Korea Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Australia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. Thailand Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Sustained Release Excipients Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Sustained Release Excipients Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Sustained Release Excipients Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2022
  • 8.4. Company Profiles
    • 8.4.1. BASF SE
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. International Flavors & Fragrances, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Ashland Global
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Evonik Industries Inc
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Croda International Plc
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Gattefosse
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Merck KGaA
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic Initiatives